Successful pregnancy and long-term, post-natal maternal and offspring cardiac, vascular and metabolic health require key maternal cardiovascular adaptations over gestation. Within the pregnant decidualizing uterus, coordinated vascular, immunological and stromal cell changes occur. Considerable attention has been given to the roles of uterine natural killer (uNK) cells in initiating decidual spiral arterial remodeling, a process normally completed by mid-gestation in mice and in humans. However, leukocyte roles in much earlier, region specific, decidual vascular remodeling are now being defined. Interest in immune cell-promoted vascular remodeling is driven by vascular aberrations that are reported in human gestational complications such as infertility, recurrent spontaneous abortion, preeclampsia (PE) and fetal growth restriction. Appropriate maternal cardiovascular responses during pregnancy protect mothers and their children from later cardiovascular disease risk elevation. One of the earliest uterine responses to pregnancy in species with hemochorial placentation is stromal cell decidualization, which creates unique niches for angiogenesis and leukocyte recruitment. In early decidua basalis, the aspect of the implantation site that will cradle the developing placenta and provide the major blood vessels to support mature placental functions, leukocytes are greatly enriched and display specialized properties. UNK cells, the most abundant leukocyte subset in early decidua basalis, have angiogenic abilities and are essential for normal early decidual angiogenesis. The regulation of uNK cells and their roles in determining maternal and progeny cardiovascular health over pregnancy and postpartum are discussed.
INTRODUCTION
Pregnancy is a physiological state that is unusual because it triggers angiogenesis and vascular remodeling within normal tissues of healthy adults (ovary, heart, kidney, uterus and its endometrial lining). 1 In implantation sites of species with hemochorial placentation, key regulators of endometrial arterial change are leukocytes; particularly those localized to decidua basalis, the placental bed. Vascular deficiencies and altered immunological functions during pregnancy have been linked with human pregnancy disorders, including the common, acute, emergency pathology known as preeclampsia (PE). 2 PE is a complex syndrome with multifactorial etiology that presents as maternal hypertension with accompanying systemic vascular pathology after mid-pregnancy (week 20). 3 The hypertension of PE is often attributed to defects in the modification of spiral arteries, which are terminal branches of the major left and right uterine arteries. Human spiral arteries perfuse the intervillous space, where metabolic exchanges occur between mother and the conceptus-derived placenta. Humans have ,100 uterine spiral arteries and typically ,70 will modify. 4 Observations of a well-remodeled spiral arterial system in many PE patients and impaired remodeling in normotensive pregnancy complications challenge the simple structure-pressure hypothesis.
In mice, where the maternal-fetal interface develops as a labyrinthine exchange area, mutant strains (for example, Rag2 2/2 c c 2/2 ; NK 2 T 2 B 2 ) exist that show no spiral arterial modification during pregnancy. These strains have normal pregnancy outcomes including normal values and typical fluctuations in gestational blood pressure. 5 Hypertensive, PE-like mouse models also exist. In one, blastocysts transduced with a lentiviral vector expressing hsFLT1 (an anti-angiogenic factor) the levels of hsFLT1 can be detected early in pregnancy, and gradually drive to late PE-like hypertensive and renal consequences. 6 Mouse spiral arterial remodeling is seen histologically over gestation days (gd) 10-12 of the 19-20 day pregnancy 5, 7 and is a process that includes downregulation of arterial markers and acquisition of venous antigen expression. 8 Thus, spiral arterial remodeling is a mid-gestational event that coincides with the completion of placental and fetal differentiation/development and the onset of rapid fetal growth. Modified spiral arteries therefore support the latter half of gestation. Extensive decidual vascular modification occurs prior to spiral arterial remodeling, establishing the conditions for implantation success and early conceptus development and growth. This early phase is thought to be the interval during which the pathogenesis develops that restricts the physiological process of spiral arterial remodeling. Maternal and conceptus compensations for pathological decidual angiogenesis occur and these adaptations may underlie aspects of the postpartum cardiovascular health compromises associated with human pregnancy complications.
Studies of early human decidual angiogenesis are limited to culture models and to materials collected during elective pregnancy termination. This has made rodents, especially genetically modified mice, key models for developing concepts concerning early human implantation site development. Parallels exist in the timing and sequence of developmental events between these species (http://embryology.med.unsw.edu. au/embryology/index.php?title5Mouse_Development). Both species have hemochorial placentation, which evokes decidualization, decidual leukocyte accumulation and leukocyte-promoted angiogenesis in decidua basalis. Here, early, pre-placental mouse pregnancy will be considered between gd4.5 (day of blastocyst implantation and initiation of decidualization) and gd9.5 (day trophoblast enters lumens of maternal decidual vessels opening the placental circulation) with copulation plug detection considered gd0.5. Early human pregnancy will be addressed between day 3 following the ovulation-promoting release of pituitary luteinizing hormone (LH; endometrial pre-decidualization) and week 12 (end of first trimester). We will emphasize the role of leukocytes in driving early decidual angiogenesis in mice and humans and how the murine data offer promising findings that may lead to improvements in the quality of human pregnancies. Literature on lymphocyte-promoted implantation site angiogenesis in species with less invasive placentation and limited to no endometrial decidualization is not discussed.
DECIDUALIZATION CHARACTERIZES HEMOCHORIAL PLACENTATION
Decidua is a transient uterine tissue shared by mammals with hemochorial placenta (mice, humans and numerous other species). The hemochorial placenta is characterized by an invasive conceptus epithelium, the trophoblast, and by erosion of maternal tissue layers within implant sites that results in maternal blood directly bathing trophoblast cells. In a hemochorial placenta, both decidua-based and circulating maternal immune cells have the potential for direct contact with trophoblast cells or with the subcellular particles that trophoblasts shed. 9, 10 In humans, decidualization (formation of decidua)
is initiated by gains in ovarian progesterone (P4) and occurs throughout the entire endometrium prior to conception (between days 3-8 post LH). In the absence of blastocyst implantation, P4 levels decline and the modified endometrium is shed during menses. With blastocyst implantation, early decidua develops further and persists throughout gestation. 11 In mice, endometrial decidualization occurs later, initiated by blastocyst attachment to the uterine epithelium (gd4.5) and is localized to implantation sites. 12 Blastocyst attachment with trophoblast invasion is considered endometrial wounding. In mice appropriately primed with hormones, mechanical endometrial wounding or placement of foreign material such as agarose beads, oil or suture material into the uterine cavity triggers endometrial decidualization. This conceptus-independent tissue called deciduoma (single site) or deciduomata (multiple sites), mimics early decidua and is commonly studied. Deciduoma, like normal decidua, provokes regionalized leukocyte recruitment 13 and early angiogenesis. Deciduoma is more transient than true gestational decidua, shows differences in gene expression profiles 14 and will not be further discussed. The importance of deciduoma is its clear illustration that leukocyte recruitment into early decidua is exclusively a maternal physiological response, independent from the conceptus, fetal antigens and any components of the male ejaculate.
Endometrial fibroblasts that transdifferentiate into decidual cells 15 play roles in nutritional sensing, endocrinological regulation, immune tolerance and in evaluation of embryo quality. [16] [17] [18] Decidua is not a uniform tissue but is composed of a series of anatomically and developmental time course-defined unique subdomains that favor (i) recruitment of specific leukocyte lineages including suppression of the entry of other immune cell types [19] [20] [21] [22] [23] [24] and (ii) formation of unique, transient, regional vascular networks (angiogenesis). 25, 26 Decidua is absolutely required for human and mouse pregnancy. 27 In humans, decidualization is initiated around blood vessels and at the base of the uterine glands. Continued stimulation by estrogen (E2) and P4 induces the spread of decidualization throughout luteal phase and gestational endometria. 28 In mice, decidualization is an anatomically polarized process. It begins on the anti-mesometrial side (anti-mesometrial decidua) of the uterus at blastocyst attachment sites. A primary decidual zone (PDZ) forms that surrounds the implantation chamber and is considered to be avascular. 29 By gd5.5, stromal cells next to the PDZ proliferate and differentiate to form an overlying vascular secondary decidual zone (SDZ). The SDZ is fully developed by gd6.5. 29 Slightly later, decidualization spreads into the mesometrial region (side where major branch orders from the uterine arteries arborize 30 ) to form decidua basalis. 15 Decidua basalis is always colocalized to the side of the uterus where placental development occurs. Histological approaches permit clear identification of the different decidual regions in mice (Figure 1 ) through the shapes and arrangements of the decidual cells, the regionally distinctive vascular networks 25 and by the leukocyte enrichment that is restricted to decidua basalis. It is critically important to recognize that decidual regions differ and that studies of pregnancy-enriched decidual immune cells in mice are appropriate only within the context of decidua basalis.
DECIDUA BASALIS-RECRUITER OF SELECTED, SPECIALIZED IMMUNE CELLS
Leukocyte populations fluctuate under ovarian steroid hormone influences in cycling (i.e., non-pregnant) endometrium and myometrium. [31] [32] [33] In humans, ovulation and rising ovarian P4 production promote a marked increase in leukocyte numbers, elevating them to 40% of all endometrial cells in the mid-late secretory phase of the menstrual cycle. 31 This gain in leukocyte numbers is primarily due to the accumulation of uterine natural killer (uNK) cells. In mice, uNK cell numbers also increase dramatically during development of decidua basalis, while increases in macrophages, monocyte-derived cells and dendritic cells are more prominent in the underlying myometrium. T cells, including regulatory T cells, are low abundance cells in early mouse decidua basalis with most being intravascular or in myometrium. 34 In contrast to humans, B cells are relatively common in early mouse decidua (between 5% (gd5.5) and 20% (gd9.5)). 25 Thus, decidua basalis permits selective entrance of leukocyte subsets and this selection may be of critical importance for maintenance of tolerance to oncofetal and to paternally-inherited antigens. 34 Studies in mice additionally show that the selected entry of uNK cells into early decidua optimizes angiogenesis. This influences the timing of uterine lumen closure and thereby the appropriate rate of early fetal development including initiation of trophoblast invasion. 26 Mouse uNK cells NK cells reside in non-pregnant uterus and are identified as CD3
CD69
2 cells that are additionally NK1.1 1 in C57BL/6 (B6) mice. 35, 36 With differentiation of decidua basalis, a unique subset of highly proliferative uNK cells suddenly appears that differentially expresses N-glycosylates on their surfaces and in the membranes surrounding their numerous cytoplasmic granules. N-glycosylates are recognized by Dolichos biflorus agglutinin (DBA) lectin, which binds exclusively to terminal N-acetyl-galactosamine groups expressed by mouse but not rat or human uNK cells. 37 Figure 1 Transverse histological sections of normal C57BL/6 mouse implantation sites at gd8.5. In a, a paraffin-embedded section stained with DBA lectin and counterstained with hematoxylin; the morphological differences between anti-mesometrial and mesometrial decidua are illustrated. The conceptus (c) is located in the anti-mesometrial decidua where the blastocyst implanted and invaded. The PDZ is regressing, but some remains and is seen in this image. The SDZ overlies the PDZ. The invasive trophoblast is present as a placental primordium called the EpC that originates from the polar trophoctoderm of the blastocyst. DB is developed with a unique pattern vascular network (pattern of unstained spaces). DB is on the side of the uterus where the major arterial vessels are located. The UA branches penetrate the memosometrium and will arborize into the developing decidua. A residual UL is present at gd8.5. Large LVS are present in the LD. An enormous influx of DBA 1 uNK cells is selectively localized in the DB (*). The Myom is also highly vascularized and becomes thinner as pregnancy proceeds. In b, the DB is shown as live tissue, whole-mount stained using fluorochrome-tagged antibodies to identify subsets of mouse uNK cells, DBA 1 KLRA3 low NK cells (green) and DBA
2

KLRA3
high uNK cells (red) (bi). The detail of distinct subsets can be observed in (biii), an image from the lateral decidua. Whole-mount using anti-CD31 shows the endothelium of large vessels in the DB near the Myom (bii). Bars: bi: 200 mm; bii: 100 mm; biii: 40 mm. DB, decidua basalis; DBA, Dolichus biflorus agglutinin; EpC, ectoplacental cone; gd, gestation days; LD, lateral decidua; LVS, lateral venous sinuses; Myom, myometrium; PDZ, primary decidual zone; SDZ, secondary decidual zone; UA, uterine artery; UL, uterine lumen; uNK, uterine natural killer. , although many other granule-enclosed products have been identified such as mucin-1, and enzymes. 21, [42] [43] [44] The cytoplasmic granules are acquired during uNK cell maturation when cell diameters expand to reach 40-100 mm. Thus, granule numbers and cell diameters are considered measurements of uNK cell maturity. The most mature, granule-rich uNK cells populate decidua basalis, are post-mitotic and become senescent cells that may have highly enabled secretory capability. 45 Smaller, agranular and granulated uNK cells that remain proliferative are enriched in a specialized structure, the mesometrial lymphoid aggregate of pregnancy (MLAp). The MLAp develops about gd8.5 between the 2 layers of uterine wall smooth muscle at each implantation site. 46 MLAps are leukocyte-enriched, ring-like structures that surround the major arteries and veins that supply implantation sites until term. 44, 46 While decidual DBA 1 uNK cells increase in number during the pregnancy (peak over gd10.5-14.5), DBA 2 uNK cell numbers maintain constant 36 and become proportionally reduced to ,10% of uNK cells by mid-pregnancy. The DBA lectinbased, differential phenotype appears to reflect distinctive uNK cell subsets as demonstrated by biased gene expression. DBA 1 uNK cells are an angiogenic subset that has relatively more abundant expression of transcripts for Vegf, Pgf, Il22, Ren1 and Ace, while the DBA 2 uNK subset has relatively more abundant expression of transcripts for Ifng, Cma1 and Nppa. 47 At the protein level, DBA 1 uNK cells express Delta-like ligand (DLL)1, 48 a molecule with roles in vascular branching and arteriogenesis, 49, 50 while the DBA 2 uNK cell product IFNG is important for spiral arterial remodeling. 51 It is unknown if these differences represent separate cell lineages, stages of maturity or differential activation via specific receptor/ligand interactions. Only DBA 1 uNK cells differentiate upon adoptive bone marrow transplantation to alymphoid (Rag2 52 confirming their source as homed, extra-uterine cells. The DBA 1 uNK cell subset is still a mixed cell population with only some cells making vascular endothelial growth factor A (VEGFA). Although distinctive, each subset has the potential to promote decidual vascular development. 2 and they are not cytotoxic. 53, 56 In contrast, most blood NK cells are CD56 dim CD16 1 , a phenotype associated with cytotoxicity. 53, 54 Human uNK cells express killer cell immunoglobulin-like receptors (KIRs) at higher frequencies than blood NK cells, 55 and they express a range of angiogenic factors (VEGF, placental growth factor (PGF), ANG2 and TGFB1). [56] [57] [58] Critical roles for CD56 bright CD16 2 uNK in early phases of uterine vascular remodeling and in regulation of trophoblast invasion were established from human tissue grafting to immune-deficient mice 59 and from in vitro explant studies. [60] [61] [62] [63] [64] UNK cells account about 70% of decidual leukocytes in early pregnancy. 65, 66 Our recent data and that of others have shown that the human uNK cell population is maintained at this percentage in healthy pregnancies until at least week 20 of gestation. Human uNK cells express high levels of VEGF [56] [57] [58] 62 and IFNG. 67 After week 20 of gestation, when human decidual samples are rarely available, uNK cell numbers decline and are at about half of their peak number by term. 67 Trophoblasts have unusual expression of major histocompatibility complex (MHC) antigens, expressing HLA-G, -C and -E but not -A or -B. Genetic studies established that specific fetal maternal combinations of HLA-C and specific KIR expressed by uNK cells associate with elevated risks of infertility and pregnancy pathologies. The genetic haplotypes associated with these clinical problems are those in which KIR fail to activate uNK cells. [68] [69] [70] Using explant studies, we recently observed that interactions with trophoblasts stimulate uNK survival and proliferation and decrease uNK cell expression of the activating receptor CD314/NKG2D (Zhang J, Dunk C, Lye JS et al., submitted manuscript). The study of human endometrial and decidual leukocytes is challenging with the global positioning of maternal leukocytes within implantation sites undefined. However, a series of standardized approaches have been successfully and widely employed to study the clinically available specimens that are limited in gestational interval, biopsy size and tissue integrity. These approaches are summarized in Figure 2 . Biobanks that provide tissue array sets of well-characterized patient samples enlarge the community of investigators able to directly investigate human decidual immune cells (http:// biobank.lunenfeld.ca).
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Mechanisms supporting recruitment of NK cells to decidua
Emigration of circulating leukocytes into tissue has three stages: (i) leukocytes adhere and begin to roll along endothelium and then stop, firmly tethered; (ii) the leukocytes then migrate through the endothelium and basement membrane; 71 finally, (ii) the leukocytes migrate within the tissue directed by chemokine and chemokine scavenging gradients. 72, 73 Postcapillary venules are the usual site for leukocyte exit from the circulation; however, uterine leukocytes have an arterial affinity. Recent studies indicate that arterioles, when exposed to stress or pro-inflammatory molecules, can alter their barrier function and attract leukocytes using P-selectin and L-selectin, intercellular adhesion molecule 1 and vascular cell adhesion molecule 1. 74 Importantly, these signals vary in their distribution and levels of expression along an artery. 74 In mice, endothelial adhesion molecules that participate in the leukocyte homing to decidua include vascular cell adhesion molecule 1 and mucosal vascular addressin cell adhesion molecule 1. At the time uNK cells are first recruited to early mouse decidua, endothelium in the basalis expresses vascular cell adhesion molecule 1 alone and at high levels. 75 Mucosal vascular addressin cell adhesion molecule 1 is expressed in lateral decidual sinusoids where a4b7 integrin 1 (ITGA4/ITGA7) cells are localized. Individual expression of ITGA4 or ITGA7 is described in uNK cells at this gestational interval. 75, 76 Interactions of chemokines expressed by decidual cells and their receptors on leukocytes also regulate leukocyte entrance to decidua basalis. Chemokines involved in leukocyte recruitment into mouse decidua basalis are still largely unknown. We have demonstrated that CCL3, CCL5 and CCXCL3 do not participate in uNK cell homing. 77, 78 Erlebacher's group demonstrated that the IFNG-regulated inflammatory chemokines CXCL9, CXCL10, CXCL11 and CCL5 are silenced in decidua but not in the myometrium. 34 Recently CXCL14, a chemokine that recruits a number of leukocytes binding to CXCR4 was studied in mouse decidua. CXCL14 expression increases in decidua from gd9.5-13.5 and in the Cxcl14 2/2 mouse, uNK cell numbers are lower than expected in gd13.5 decidua basalis and MLAp. It is as yet unclear how these data should be interpreted because the authors showed that uNK cells themselves were the major source of this chemokine. 79 Other factors such as hemoxygenase 80 and adrenomedulin regulate uNK cell numbers in decidua basalis. 81 For adrenomedulin, a mechanism potentially controlled by CCL7, CCL17 and XCL1, but not by CXCL9 and CXCL10 has been proposed. 81 Human uNK cell homing may differ from that in mice. Perivascular and endothelial cells in human decidua express CCL21, CCL22, CX3CL1, CXCL10, CXCL11 and CXCL12. [82] [83] [84] [85] CXCL10 and CXCL12 bind to CXCR3 and CXCR4, receptors expressed by blood leukocytes including CD56 bright NK cells. 86 In a prospective serial study of women for a year over pregnancy and early postpartum, we addressed ITGA4, L-selectin, CXCR3 and CXCR4 expression by blood leukocyte subsets. We found that adhesion and chemokine receptor expressions fluctuate over normal pregnancy, particularly on type 1 (IL18R 1 ) and type 2 (IL1RL1 1 ) CD56 bright cell subsets. In contrast, blood leukocytes from pre-conception type 1 diabetic patients, a clinical population at high risk for PE, had stable expression of these molecules. These data suggest that diabetic women have impaired uNK progenitor cell recruitment to the uterus that subsequently restricts decidual angiogenesis and may compound their risk for PE (Burke SD, Seaward AVC, Virani S, Ramshaw H, Smith GN, Croy BA, Lima PDA, submitted manuscript).
VASCULAR DEVELOPMENT IN THE EARLY DECIDUA
Angiogenesis is the growth of blood vessels from the existing vasculature. Decidua is a highly vascular tissue that displays two commonly recognized forms of angiogenesis: sprouting and intussusceptive. 25, [87] [88] [89] Sprouting angiogenesis is characterized by endothelial cell sprouts that grow towards a tissue devoid of blood vessels but expressing an angiogenic gradient. 87 Intussusceptive angiogenesis is the formation of blood vessels by invagination of interstitial tissues into existing vessels forming transvascular tissue pillars that then split the blood vessel. 87 During sprouting angiogenesis, parenchymal cells detect hypoxia and respond by secreting angiogenic factors that will sensitize the nearest capillaries and induce endothelial cell proliferation and migration. Endothelial cells adopt two specialized phenotypes: tip cells and stalk cells. Tip cells are non-proliferative, spearheading or guiding vascular sprouts. 90 Their transformation induces adjoining cells to become the highly proliferative stalk cells. 91 Stalk cell division elongates the vessel in a new dimension behind the pioneering tip cell. Differentiation of each of these endothelial cell phenotypes requires VEGF and NOTCH signaling. [90] [91] [92] [93] [94] [95] [96] The steps in sprouting angiogenesis include: (i) detection of an angiogenic gradient by an endothelial cell; (ii) increase in vascular permeability; 91, 97, 98 (iii) enzymatic degradation of endothelial basement membrane and the extracellular matrix; 91, 99 (iv) endothelial cell migration and proliferation; 91 (v) tubulogenesis; 100-102 and finally (vi) pericyte recruitment to stabilize the new vessel. 103 Each step is finely coordinated by angiogenic factors that supplement the major regulation by VEGF and NOTCH-signaling family members.
Mechanistic understanding of early decidual angiogenesis in humans is limited. Even in mice, the understanding of early decidual angiogenesis remains challenging. In mice, vascular networks differ between decidual regions (anti-mesometrial, lateral or basalis) and they are constantly changing over pregnancy. Differing stimuli may promote angiogenesis in each decidual region, but participation of VEGF family members appears to be central. Whole-mount staining (Figure 1b ) of endothelium by CD31 showed very early anti-mesometrial angiogenesis (gd5.5-6.5) is sprouting rather than intussusceptive angiogenesis. 25 Vessels closer to the PDZ are wider than those towards the opposite side of the SDZ where the vessels are narrow and highly branched. At this gestational time, PDZ is reactive with a histochemical hypoxia probe. 104 The hypoxiainduced factors (HIFs) (HIF1A and HIF1B) are strongly expressed in the SDZ and this coincides with VEGFA expression by decidual cells and FLT1 (also known as VEGFR1) expression by endothelial cells. 88, 105 HIF is a strong inducer of VEGF family member expression. 106 By gd7.5, anti-mesometrial angiogenesis is less evident, and vessels appear more mature (pruned). 25 Within 24 hr, expansion of trophoblast will compress the anti-mesometrial decidua and its blood supply will regress. Mesometrially, decidua basalis has low HIF expression, 88 which is likely explained by the proximity of the uterine arteries. These arise from major aortic branches to the ovary and pelvis, and are oxygen enriched. 30, 107 At gd4.5-5.5, Vegfa mRNA is detected in epithelium around the embryonic implantation crypt and in stromal cells. 108 At gd6.5, Vegfa mRNA becomes elevated in decidua basalis, despite low HIF in this region. Because P4 is essential for decidual development and also regulates Vegfa transcription, P4 could be important for indirectly elevating VEGFA in DBA 1 uNK cells. 44, 47, 109 However, since uNK cells lack P4 receptor expression, 110 mechanisms for VEGFA regulation in uNK cells await characterization.
Regional differences in early decidual angiogenesis are very apparent by whole-mount immunohistochemistry. At gd5.5-6.5, the central decidua basalis (a CD45 1 cell-enriched region with prominent DBA 1 uNK cell content (Figure 1) ) has narrow vessels that are highly branched and more abundant than in other decidual regions such as the lateral decidua. This non CD45 1 cell enriched region shows intussusceptive angiogenesis (web-type). 25, 26 With the advance of pregnancy (gd8.5), vessels of the central decidua basalis become less defined and wider suggesting intense intussusceptive remodeling, while large vessels along the lateral decidual margins become more apparent and arched 25, 26 as they enlarge into venous sinuses. Decidual angiogenesis occurs in mice lacking most or all uNK cells and these mice, if housed under microbial pathogen-free environments, appear to have normal fertility. However, implantation sites deficient in uNK cells have anomalous features. Thus, it is important to acknowledge that immune cells enhance the quality of decidual angiogenesis but are not essential for a basic decidual angiogenesis program. In the absence of uNK cells, onset and progression of angiogenesis are delayed. Initially delay is about 24 h in comparison with syngeneic normal mice and this becomes reduced to about 0.5 day by mid pregnancy. There is also diminished pruning of vessels and poorer development of lateral decidual sinuses. 26 The combined lack of uNK cells and of angiogenesis in decidua basalis delay uterine lumen closure. This is accompanied by delays in conceptus development and in initiation of trophoblast invasion 26 that are more likely to be secondary outcomes to the delayed lumen closure than primary outcomes from the absence of uNK cells. These outcomes have been confirmed in studies using NK cell blocking antibodies, where greatly diminished angiogenesis in the sinuses of the lateral decidua was seen at gd8.5. 88 UNK cells produce growth and recruitment factors 44, 47, 57, 109, 111 as well as tip cell inducing, 48 matrix degrading and apoptosis causing factors. 43, 44, 112, 113 These abilities align uNK cells with the cyclical vascular remodeling seen in pregnancy and postpartum vascular recovery (Figure 3) . We have postulated that the sensing and mobility of uNK cells permits them to identify implantation sites and to provide enhanced guidance to newly developing vessels enabling correct vascular development for each conceptus. This hypothesis is particularly important for litter bearing species where numbers of implantation sites vary between pregnancies. It would also be important for human pregnancies having more than one conceptus. 114 Recent reports indicate that endothelial cells use glycolytic metabolism. 115 No studies yet address the important question of whether this may also be true for the specialized uNK cell subset associated with early decidual angiogenesis.
THE ANGIOGENIC FACTORS OF HUMAN AND MOUSE UNK CELLS
VEGFA VEGF has broad biological functions including modulation of angiogenesis, vascular permeability and regulation of arterial differentiation. It also has neurotrophic activity and participates in hematopoiesis and in inflammatory responses. 116 VEGF targets vascular endothelium, smooth muscle cells and certain blood cells. 117 The VEGF family has seven members: VEGFA, Figure 3 A schematic illustration of uNK cell actions (steps 1-5) during decidual angiogenesis. uNK cells secrete angiokines and vasoactive factors. uNK cells also produce enzymes and store apoptotic factors that have structure modifying functions during angiogenesis. In (1), MMPs participate in ECM degradation that allows endothelial cell growth and migration. ANGPT1/2 control vascular integrity and regulate mural cell disruption and ECM breakdown in (1) and (2) . Perforin may act as an inducer of apoptosis in mural cells of vessels where the endothelial sprout will form (1), but may also participate in neovascular pruning (5). VEGFA, the major regulator of angiogenesis contributes to steps (2) , (3) and (4) . VEGFA participates in tip cell formation and endothelial cell proliferation (2) . VEGFA chemoattracts endothelial cells and pericytes. DLL1, a Notch signaling protein, guides the direction of endothelial cell growth and determines arterial fate. PGF and DLL1 contribute to vessel enlargement (2) . The maturation and stabilization of neovessels is driven by secreted PGF and membrane-associated DLL1, both uNK cell products (3) . In addition to sprouting angiogenesis, intussusceptive angiogenesis may also be driven by VEGFA and PGF secreted by uNK cells during the splitting of established vessels. The homing, activation and maturation of angiogenic uNK cells depend upon activation receptors, such as Ly49 and NCR1 in mice and S1PR5 in humans. ANGPT, angiopoietin; DLL, delta-like ligand; ECM, extracellular matrix; MMP, metalloproteinase; NCR, natural cytotoxicity receptor; PGF, placental growth factor; S1PR, sphingosin-1-phosphate receptor; uNK, uterine natural killer; VEGFA, vascular endothelial growth factor A.
Pruning of vessels
B, C, D, E, F and PGF, 118, 119 and three tyrosine kinase receptors: fms-like tyrosine kinase FLT1 (known as VEGFR1), the kinase domain region (known as KDR/VEGFR2) and FLT4 (known as VEGFR3). In angiogenesis, VEGF-A is the major regulator.
VEGFA binds to FLT1 and KDR. KDR seems to be a more potent inductor of VEGF-induced mitogenesis and permeability. 120, 121 Additionally, ligation by this receptor induces gene transcription, cell proliferation 122 and cytoskeletal reorganization followed by cell migration. 119, 123, 124 VEGFA has lower affinity for FLT1 than KDR. 125 A soluble form of FLT1 (sFLT1) also binds to VEGFA and in doing so drives anti-angiogenic effects. SFLT1 is a splice variant of FLT1 produced by a variety of tissues 126 that is highly implicated in PE. [127] [128] [129] During pregnancy, VEGFs and their receptors are present in human endometrial cells of several lineages 56, 57 and disturbances in levels of expression could have unwanted gestational sequences. CD56
1 uNK cells within the placental bed area are a prominent source of VEGF, as well as IL8, angiopoietin 1 (ANGPT1), ANGPT2 and TGFB1. Together these factors may drive not only decidual vascular growth, but also trophoblast invasion. 59, 60 Flow cytometry has demonstrated that the majority of freshly isolated, first trimester CD56
1 uNK cells express VEGF 59, 62 ( Figure 4) (Figure 5 ), close to the uNK cell membrane. Such VEGFA 1 vesicles are abundant, suggesting that VEGFA is constitutively secreted by uNK cells. 44 Depletion or activation defects of DBA 1 uNK cells cause diminished VEGFA expression, reduced blood vessel density and reduced numbers of large sinuses. 26, 88, 132, 133 In some of these mouse models, subfertility 134 and intrauterine growth restriction 26, 133, 134 are present. However, undefined compensatory mechanisms develop that successfully support these pregnancies to term. PGF PGF was originally isolated from placenta. It is not highly expressed in normal embryonic or adult tissues, but is elevated in many tumors and in ischemic heart repair. [135] [136] [137] [138] In humans, PGF is encoded by two genes, PGF1 and 2. Both isoforms interact with the receptor FLT1 but not with KDR; only PGF2 binds neuropilin-1, 137 a coreceptor. The mouse has only one PGF isoform that corresponds to human PGF2. PGF is angiogenic, chemotactic and a survival factor for endothelial cells and monocytes. Binding of PGF to FLT1 can induce endothelial cell proliferation, differentiation or apoptosis and mediate responses to different stress stimuli, as inflammation. 136, 139 UNK cells are among the sources of decidual PGF. 56, 59, 111 Many PE patients have significantly lower levels of circulating PGF than normal pregnant women and low maternal PGF is detected in first trimester prior to clinical signs. 140, 141 All women who progress to PE have later elevations in plasma sFLT1. 126 Measurement of PGF or of the sFLT1 : PGF ratio is used as a biomarker for the diagnosis of PE. 142 Generally, these Freshly isolated decidual leukocytes were pretreated with (red line) or without (blue line) the S1P receptor modulator Fingolimod (FTY720; 5 mM; Cayman Chemical Ann Arbor, MI, USA) for 1.5 h at 37 uC, then followed with intracellular cytokine staining. The VEGF and IL8 expressions of CD56 1 uNK were plotted with FMO. FMO, fluorescence-minus-one; S1P, sphingosine 1-phosphate; uNK, uterine natural killer; VEGF, vascular endothelial growth factor. measurements are considered to reflect placental (and thus fetal) health rather than decidual biology.
Studies in mice found that relative Pgf mRNA levels are reduced in the decidua of alymphoid compared to normal mice 111 and that deletion of Pgf affected the proliferation and/or differentiation of mouse uNK cells. 111 In addition, conceptus-derived Pgf seems to be important to maternal vascular adaptations. Conceptus rather than Pgf deletion impairs the development of neovessel branching in decidua basalis (gd6.5-8.5) (Ratsep MT, Tolusso L, Yamada AT, Joazeiro PP, Carmeliet P, Adams MA, Croy BA, submitted manuscript). PGF is also involved in the structural and molecular adaptations of the mother's heart after gd12.5, particularly the left ventricle (Aasa KL, Zavan B, Wang PG, Ventura MN, Tse MY, Carmeliet P, Pang SC, Croy BA, submitted manuscript). Thus, expression of PGF in the placental bed and the maternal circulation needs to be strictly regulated to achieve the balanced angiogenesis and cardiovascular adaptations that favor healthy pregnancies.
ANGPT1/2
ANGPTs are proteins promoting vascular growth; they bind to the endothelial-specific receptor tyrosine kinase 2 (also called TIE2 and designated CD202B). In humans, there are seven ANGPT-like molecules 143, 144 with ANGPT1 and ANGPT2 having key roles in regulating vascular integrity and quiescence through the transduction of survival and migration-inducing signals. Many different cell types constitutively express ANGPT1 while ANGPT2 is almost exclusively expressed by endothelial cells. Both ANGPT1 and ANGPT2 bind to the same site in the extracellular domain of tyrosine kinase 2 in quiescent resting endothelial cells to modulate angiogenesis. 144 Collective data suggest that early uNK cells along with monocytes and trophoblasts are major sources of ANGPTs to regulate decidual spiral artery modeling and normal placentation. 145, 146 ANGPT1 and ANGPT2 are detected in human uNK cell culture supernatants and both are at lower levels in second than in first trimester samples. 57 Increases in ANGPT1, ANGPT2 and IFNG (at 10 ng/ml level) are proposed to disrupt human vascular smooth muscle cells and breakdown extracellular matrix components 63 to enhance early angiogenesis. In mice, early decidual expression of ANGPTs is reported 147, 148 but none of the studies identified the cellular sources of the ANGPTs.
Metalloproteinases (MMPs)
During angiogenesis, degradation of endothelial basement membranes is mediated by matrix MMPs, a family of enzymes that proteolytically breakdown various components of extracellular matrix. 149 Immunohistochemistry and in situ hybridization results indicate that dynamic changes occur in MMP profiles at the human maternal-fetal interface over first trimester when MMP9 and TIMP1/3 increase, but TIMP2 decreases. 150 UNK cells are a decidual source of MMPs. In decidua from human early pregnancies, CD56
1 uNK cells are the predominant source of MMP2, as well as of their inhibitor TIMP2. 151 The pattern expression of various MMPs and TIMPs suggests that they are involved in the invasion of extravillous trophoblast during implantation and placentation. Data from a placental-decidual co-culture model indicate that active MMP9 is important in decidual leukocyte-mediated vascular remodelling. 61 Application of a pan-MMP inhibitor significantly interrupted arterial remodeling in the presence of uNK conditioned medium. 63 In mouse decidua basalis, MMP2 and MMP9 are localized around maternal blood vessels; however, the cellular source is not reported.
152
NOTCH-signaling in decidual angiogenesis NOTCH signaling is an evolutionarily-conserved pathway involved in cell lineage commitment determination in all metazoans. 93 During angiogenesis, NOTCH signaling has a critical role in tip and stalk cell fate decisions. 93, 119 Mammals have four NOTCH receptors (NOTCH1-4) and five canonical ligands of the Delta-Serrate-Lag type (Jag1 and Jag2 and DLL1, DLL3 and DLL4). 153 In mouse and human pregnancies, NOTCH signaling members are expressed in the uterus, and are described as being important for decidualization, 154, 155 invasion of trophoblast and arterial differentiation/function. 155 In PE patients, normal expression of NOTCH ligand JAG1 is absent in perivascular and endovascular trophoblasts, suggesting a potential role for deficits in NOTCH signaling in the pathogenesis of PE. 155 Human uNK cells express NOTCH1 and NOTCH2, and their ligand engagement leads to increased IFNG secretion. 156 In mice, DBA 1 but not DBA 2 uNK cells express DLL1.
DLL1
1 cells are localized in the central decidua basalis suggesting a role in the induction of endothelial tip cell differentiation and in the promotion of perpendicular vascular growth. 48 Perforin: has it a role in decidual angiogenesis? Perforin is present in the cores of the secretory-lysosome granules of many but not all DBA 1 uNK cells ( Figure 5 ). Secretorylysosome granules are organelles with double compartments: a cap that contains lysosomal enzymes and a dense core of proteins including perforin for secretion. 44 Perforin is expressed by 45% of DBA 1 uNK cells at gd9.5. 44 For years, expression of perforin by DBA 1 uNK cells early in pregnancy was linked to the classical NK cell lytic activity of anti-viral immunity. 157 However, the findings that 1) nitric oxide synthase 2, an inducible enzyme essential for nitric oxide synthesis (NO is a potent vasodilator) regulates perforin in mouse DBA 1 uNK cells; 158 and that 2) DBA 1 Vegfa 1 uNK cells often co-express perforin ( Figure 5 ) 44 provides a newer postulate for perforin function as an angiokine in early decidua. Perforin might initiate smooth muscle cell death to allow the migration and sprouting of decidual endothelial cells as suggested in a model of abdominal aortic aneurysm. 159 Alternatively, perforin may prune nascent vessels into their mature forms. Pruning is an important step during angiogenesis and in the neonatal mouse retinal vascular bioassay, vascular pruning has been linked to activated leukocytes, some identified as cytotoxic T cells 160 that may express perforin.
UNK CELL RECEPTORS THAT REGULATE ANGIOGENESIS IN DECIDUA BASALIS: WHAT IS NEW?
Ly49 receptors on mouse uNK cells Murine NK cells express Ly49 receptors that bind to MHC class I molecules expressed by all nucleated cells. Interactions between Ly49 receptors and MHC antigens determine NK cell inhibition, activation and maturation. 161 Ly49 receptors are homodimeric type II glycoproteins of the C-type lectin superfamily. Ly49 receptors are structurally distinct from but serve similar functions to human KIR in terms of regulating NK cell responses to MHC. 2, 162 Mouse uNK cells express Ly49 receptors 36, 134 and, in B6, two activating receptors: Ly49 D and H, and 4 inhibitory receptors: Ly49 A, C, I, G are present. 163 We addressed the importance of Ly49 receptors in the activation of uNK cell functions using a pan-Ly49 knockdown mouse model. In this model, downregulation of Ly49 receptors impaired fertility, early fetal growth and spiral arterial remodeling. Pregnant females with pan Ly49 downregulation had deficient decidual angiogenesis at gd6.5 and decreased VEGFA expression by DBA 1 uNK cells at gd9.5-10.5. 134 These data suggest that the reported human gestational complications linked to conceptus genotypes unable to activate uNK cells maybe based upon inadequate uNK cell-driven angiogenesis.
Natural cytotoxicity receptor (NCR) 1 on mouse uNK cells Mouse uNK cells express the activation receptor NCR1, the ortholog of human NKp46. 164, 165 NCR is expressed during early stages of NK cell development and remains constitutively expressed during subsequent differentation. 166 The DBA 1 uNK cell subset has relatively higher numbers of Ncr1 transcripts than DBA 2 uNK cells. 132 The ligands of NCR1 are only partially characterized, 167 but are independent from MHC and receptor engagement via specific antibody is usually used to experimentally trigger this receptor. Neither NCR1's role in uNK cell activation nor its potential implantation site ligands are defined. However, uNK cells from mice lacking functional NCR1 (Ncr1 Gfp/Gfp ) are smaller suggesting immaturity. Reduced uNK cell maturation in this transgenic mouse is accompanied by defects in angiogenesis within the decidua basalis, such as delayed endothelial tip cell induction and the later gestational outcome of impaired spiral arterial remodeling. 132 In contrast to pan-Ly49 knockdown mice, uNK cells from mice unable to be activated via NCR1 lack solid core ultrastructure in their cytoplasmic granules and have elevated levels of immunohistologically detectable VEGFA on gd8.5 and 10.5 (Felker AM, Croy BA, unpublished data). Thus, different ligands within implantation sites regulate distinct aspects of uNK cell biology and function.
Sphingosin-1-phosphate receptor (S1PR) 5 on human uNK cells Sphingosine-1-phosphate (S1P) signaling has large impacts on immune cell behavior within lymphoid tissues.
168 S1P can increase inflammatory responses to both innate and adaptive immune challenges, while S1P concentration gradients affect immune cell trafficking. In mouse pregnancy, gd11.5 homogenates of whole conceptuses have similar S1P levels to adult blood.
168 S1P concentrations are not reported for human placental or decidual samples. Sphingosine kinase 1, which catalyzes the phosphorylation of sphingosine to form S1P, 169 is detected in human decidua parietalis at levels that correlate positively with increasing gestational age.
170 S1P signaling regulates NK trafficking through different organs, 171 primarily via the S1P receptor, S1PR5. 172 We showed that first trimester human uNK cells have much higher levels of S1PR5 expression than peripheral NK cells. 62 This suggests that CD56 1 CD16 2 uNK cells are more sensitive to changes in decidual S1P concentrations and signaling than circulating cells. This may affect trafficking patterns into and within decidua and adaptations towards becoming a resident decidual NK cell. 62, 173 S1P affects the angiogenic capacity of NK cells by regulating transmembrane-intracellular signals. S1P-S1PR5 has been shown to regulate angiogenic molecules in uNK cells. 62 When first trimester human uNK cells were exposed to the S1P antagonist FTY720 (fingolimod), S1PR5 expression as well as angiogenic capacity (i.e., VEGF production) were greatly decreased. In turn, this impaired uNK-VEGF-mediated trophoblast migration and tube formation by human umbilical vein endothelial cells in culture. 62 Of note, S1PR5-mediated angiogenesis appears to act via VEGF but not IL8, although both are critical for decidual vessel transformation 59 ( Figure 4) . A very recent study reported that S1P induces IL8 secretion. 174 IL8 expression in blood NK cells is confined to the immature 176 only a few cells express IL8 (Figure 4 ). Previous studies indicated that in vitro IL2 stimulation increases IL8 expression by uNK cells but IL2 is not available in vivo in human or mouse decidua. 59, 177 Thus the reactivity of uNK cells to decidual S1P signaling is conditional and is greatly influenced by the immunological, biochemical and physiological factors present in the placental bed. Of note, human uNK cell-released IL8 in nude mouse xenografts has been attributed with trophoblast cell recruitment. 59 This apparent difference points out the importance of clearly defining ages of tissues used in studies, of characterizing uNK cell actions in future studies by defined cell subsets and of validating that cells recovered from decidua are not damaged during isolation or culturing procedures. S1P signaling may modulate uNK behavior through other supportive cells within decidua. In normal human pregnancy, conceptus-derived trophoblast cells, monocytes, immature dendritic cells and T cells are observed in close contact with uNK and are thought to promote immune tolerance. 178, 179 Since the phenotype and functions of uNK cells depend upon their microenvironment, any inflammatory shift, either locally or systemically, may cause a chain reaction that alters the uNK cells' angiogenic and immune properties.
CONCLUSION
Unraveling of the physiological processes involved in decidual angiogenesis is an important step towards understanding pregnancy disorders associated with poor decidual development and poor placental perfusion and the relationships of these abnormalities to health of the conceptus and its mother during and after pregnancy. Angiogenesis-promoting leukocytes play key roles in regulation of endothelial cells of the decidua basalis, in the maturation processes of neoangiogenic vessels and in the remodeling of spiral arterioles. Establishing an adequate decidual vasculature network is crucial for placental perfusion and it determines the efficiency of metabolic exchanges between the mother and her fetus(es). At present, specialized uNK cell subsets appear to be central regulators of angiogenesis within early decidua basalis, which is a pro-inflammatory environment. The dynamic changes in early implantation sites make it challenging to define maternal and conceptus-based regulation of decidual stromal niches and the impacts of these niches upon the recruitment and terminal differentiation of uNK cells. These challenges need to be embraced, carefully examined and cautiously interpreted to successfully bring the importance of immune cell regulated decidual angiogenesis to the platform of clinical translation.
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